Li Di

174 papers and 7.9k indexed citations i.

About

Li Di is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Li Di has authored 174 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pharmacology, 57 papers in Molecular Biology and 55 papers in Oncology. Recurrent topics in Li Di’s work include Pharmacogenetics and Drug Metabolism (66 papers), Drug Transport and Resistance Mechanisms (51 papers) and Computational Drug Discovery Methods (31 papers). Li Di is often cited by papers focused on Pharmacogenetics and Drug Metabolism (66 papers), Drug Transport and Resistance Mechanisms (51 papers) and Computational Drug Discovery Methods (31 papers). Li Di collaborates with scholars based in United States, China and United Kingdom. Li Di's co-authors include Edward H. Kerns, Dennis A. Smith, Tristan S. Maurer, Nicholas A. Meanwell, Michael J. Hageman, Jarkko Rautio, Takashi Mano, Paul V. Fish, Kevin Beaumont and Bo Feng and has published in prestigious journals such as Journal of the American Chemical Society, Neurology and Nature Reviews Drug Discovery.

In The Last Decade

Co-authorship network of co-authors of Li Di i

Fields of papers citing papers by Li Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Di. The network helps show where Li Di may publish in the future.

Countries citing papers authored by Li Di

Since Specialization
Citations

This map shows the geographic impact of Li Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Di more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025